Knoll Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,100
Closed -$1.11M 37
2023
Q4
$1.11M Hold
2,100
0.92% 21
2023
Q3
$1.06M Hold
2,100
1.1% 22
2023
Q2
$1.1M Hold
2,100
1.33% 13
2023
Q1
$1.21M Hold
2,100
1.87% 12
2022
Q4
$1.16M Hold
2,100
2.61% 12
2022
Q3
$1.07M Hold
2,100
0.62% 9
2022
Q2
$1.14M Hold
2,100
0.65% 13
2022
Q1
$1.24M Hold
2,100
0.78% 12
2021
Q4
$1.4M Hold
2,100
0.77% 13
2021
Q3
$1.2M Hold
2,100
0.6% 15
2021
Q2
$1.06M Hold
2,100
0.55% 26
2021
Q1
$958K Buy
+2,100
New +$1M 0.62% 25

Other funds holding TMO

Knoll Capital Management's TMO Position: Q1 2024 in Review

Knoll Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 2,100 shares — an estimated $1.11M sold.

Knoll Capital Management first reported a position in TMO in Q1 2021 and held it in 12 quarters. The position peaked at $1.4M in Q4 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Knoll Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Knoll Capital Management sold 2,100 Thermo Fisher Scientific shares in Q1 2024, an estimated $1.11M.
  • Knoll Capital Management first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 12 quarters.
  • Knoll Capital Management's Thermo Fisher Scientific position peaked at $1.4M in Q4 2021.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Knoll Capital Management's 13F filing for Q1 2024, filed 15 May 2024.